2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Leukemia
26
Lymphoma, Non-Hodgkin
18
Sarcoma
17
Leukemia, Myeloid, Acute
16
Hematologic Neoplasms
12
Neuroblastoma
11
Neoplasms
11
Myelodysplastic Syndromes
11
Hodgkin Disease
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Breast Neoplasms
9
Burkitt Lymphoma
8
Osteosarcoma
6
Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Melanoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Rhabdoid Tumor
4
Retinoblastoma
4
Recurrence
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Myeloproliferative Disorders
4
Medulloblastoma
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Hematologic Diseases
4
Interventions
Fluorouracil
497
Bevacizumab
476
Oxaliplatin
449
Leucovorin
440
Irinotecan
408
Cetuximab
317
Capecitabine
317
pembrolizumab
142
Folfox protocol
129
Panitumumab
117
regorafenib
105
Colonoscopy
88
Nivolumab
81
IFL protocol
81
Drug Therapy
77
trifluridine tipiracil drug combination
73
Radiotherapy
66
HMPL-013
65
Blood Specimen Collection
52
Gemcitabine
49
Specimen Handling
46
Neoadjuvant Therapy
45
Standard of Care
44
Magnetic Resonance Spectroscopy
43
Biopsy
43
Chemotherapy, Adjuvant
41
Trifluridine
40
atezolizumab
38
Surveys and Questionnaires
38
Cyclophosphamide
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Mesna
×
Clear all
NCT07255664
2025-12-08
ProbeTILity
Curacell Holding AB
Phase 1/2
Recruiting
12 enrolled